These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23765731)

  • 1. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
    Zenzmaier C; Sampson N; Plas E; Berger P
    Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
    Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P
    Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.
    Sampson N; Zenzmaier C; Heitz M; Hermann M; Plas E; Schäfer G; Klocker H; Berger P
    Endocrinology; 2013 Aug; 154(8):2586-99. PubMed ID: 23720424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
    Li W; Wu CL; Febbo PG; Olumi AF
    Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
    Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
    Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.
    Bhattacharyya S; Feferman L; Tobacman JK
    Prostate; 2019 May; 79(7):689-700. PubMed ID: 30801800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia.
    Zenzmaier C; Sampson N; Pernkopf D; Plas E; Untergasser G; Berger P
    Endocrinology; 2010 Aug; 151(8):3975-84. PubMed ID: 20555034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.
    Zenzmaier C; Kern J; Sampson N; Heitz M; Plas E; Untergasser G; Berger P
    Endocrinology; 2012 Nov; 153(11):5546-55. PubMed ID: 22948216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.
    Al Shareef Z; Kardooni H; Murillo-Garzón V; Domenici G; Stylianakis E; Steel JH; Rabano M; Gorroño-Etxebarria I; Zabalza I; Vivanco MD; Waxman J; Kypta RM
    Oncogene; 2018 Sep; 37(39):5305-5324. PubMed ID: 29858602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal expression of Rab27B in prostatic epithelial cells of benign prostatic hyperplasia alters intercellular communication.
    Dai Y; Ai B; Liu Y; Pascal LE; Wang Z; Dhir R; Sun X; Jiang Y
    Int J Biochem Cell Biol; 2021 Feb; 131():105898. PubMed ID: 33285290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
    Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
    Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
    Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
    Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
    Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
    Mori F; Tanigawa K; Endo K; Minamiguchi K; Abe M; Yamada S; Miyoshi K
    Prostate; 2011 Oct; 71(14):1579-86. PubMed ID: 21394740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.